QIAGEN (QGENF) - Star of Germany's Biotechs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QIAGEN (QGENF) - Star of Germany's Biotechs

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Heribert Stiegler who wrote (30)	7/8/1997 11:12:00 AM
From: (no name provided)	of 122

If someone is going to buy QGENF at this price, then that someone is more ridiculously valued than QGENF itself. I have no problems with QGENF. Great products and good innovation. But really, $1 billion dollars for a highly competitive industry and under constant pricing pressure is absurd. Look at the valuations of competitors like LTEK and BioRad. Granted they are not directly comparable, but... LTEK sales $310M p/e 22 market cap $690M BIO sales $419M p/e 12 market cap $327M QGENF sales $54M p/e 140 market cap $934M Kafka666

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next